SlideShare a Scribd company logo
1 of 13
Download to read offline
Recommendation BUY
CMP 1348.00
Target Price 1510.00
ISIN: INE259A01022 MAY 28th
, 2014
COLGATE-PALMOLIVE (INDIA) LTD
Result Update (PARENT BASIS): Q4 FY14
STOCK DETAILS
Sector FMCG
BSE Code 500830
Face Value 1.00
52wk. High / Low (Rs.) 1522.95/1190.05
Volume (2wk. Avg ) 20000
Market Cap ( Rs in mn ) 183328.00
Annual Estimated Results (A*: Actual / E*: Estimated)
Years FY14A FY15E FY16E
Net Sales 35788.10 40082.67 44090.94
EBITDA 7143.30 8053.67 8742.17
Net Profit 5398.70 5430.62 5961.84
EPS 39.70 39.93 43.84
P/E 33.96 33.76 30.75
Shareholding Pattern (%)
1 Year Comparative Graph
COLGATE-PALMOLIVE (INDIA) LTD S&P BSE SENSEX
SYNOPSIS
Colgate Palmolive (India) Limited is India’s leading
provider of scientifically proven oral care products
with multiple benefits at various price points.
During the quarter, net profit jumps to Rs. 1323.00
mn against Rs. 1232.00 mn in the corresponding
quarter ending of previous year, an increase of
7.39%.
Revenue for the quarter rose by 11.51% to Rs.
9272.80 mn from Rs. 8315.30 mn, when compared
with the prior year period.
The Company posted a robust volume growth of 7%
for the quarter and 9% for the full year in Toothpaste
category.
Toothpaste category registered a volume market
share of 57.1% for the period Jan’14-Apr’14, an
increase of 170 basis points over the same period of
the previous year.
The Company’s Toothbrush category registered a
volume market share of 42.3% for Jan’14-Apr’14, an
increase of 100 basis points over the same period of
the previous year.
For the year ended March 31, 2014, net sales
increased by 13% to Rs. 35788.1 mn as against Rs.
31638.1 mn in the previous year.
In March, 2014, the Company has declared a third
interim dividend of Rs. 9/- per equity share of Re. 1/-
each for the financial year ending March 31, 2014.
Commercial production of toothpaste has
commenced on May 21, 2014 at Company's new
manufacturing facility set up at Sanand, Gujarat.
Net Sales and PAT of the company are expected to
grow at a CAGR of 12% and 6% over 2013 to 2016E
respectively.
PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND
COMPANY NAME (Rs.) Rs. in Mn. (Rs.) Ratio Ratio (%)
Colgate-Palmolive (India) Ltd 1348.00 183328.00 39.70 33.96 30.56 2700.00
P&G Hygiene and Health Care Ltd 3850.00 124973.80 81.33 47.34 15.52 250.00
Dabur India Ltd 180.25 313101.60 3.85 46.64 19.62 175.00
HUL Ltd 561.00 1207108.90 17.88 31.22 45.16 1300.00
Recommendation & Analysis - ‘BUY’
Net sales for the fourth quarter of current financial year 2013-14, was Rs. 9272.80 mn, an 11.51% increase over
the same quarter of the previous year and Net profit after Tax of Rs. 1323.0 mn with Earnings per share of Rs.
9.73. For the year ended March 31st, 2014, net sales increased by 13% to Rs. 35788.1 mn as against Rs. 31638.1
mn in the previous year and Net profit after Tax (including exceptional item) of Rs. 5398.7 mn with Earnings per
share of Rs. 39.70, an increase of 9% over the previous year.
The Company posted a robust volume growth of 7% for the quarter and 9% for the full year in Toothpaste and
continued to enhance its leadership position in Toothpaste category by registering a volume market share of
57.1% for the period Jan’14-Apr’14, an increase of 170 basis points over the same period of the previous year.
The flagship brands “Colgate Dental Cream”, “Active Salt”, “Max Fresh” and “Colgate Total” along with the
recently launched “Visible White” have contributed to this growth. The Company further strengthened its
leadership position in the Toothbrush category by registering a volume market share of 42.3% for Jan’14-Apr’14,
an increase of 100 basis points over the same period of the previous year.
Colgate has, for the third consecutive year from 2011 to 2013, been ranked as India’s #1 Most Trusted Brand
across all categories by Brand Equity’s Most Trusted Brand Survey and is the only brand to feature in the top
three since the inception of the survey twelve years ago. Over FY2013-16E, we expect the company to post a
CAGR of 12% and 6% in its top-line and bottom-line respectively. Hence, we recommend ‘BUY’ for ‘COLGATE-
PALMOLIVE (INDIA) LTD’ with a target price of Rs. 1510.00 for medium to long term investment.
FINANCIAL HIGHLIGHTS (PARENT BASIS)
Results updates- Q4 FY14,
Colgate-Palmolive (India) Limited engages in the
manufacture and marketing of fast moving
consumer goods in India and internationally,
reported its financial results for the quarter ended
31st March, 2014.
Months Mar-14 Mar-13 % Change
Net Sales 9272.80 8315.30 11.51
PAT 1323.00 1232.00 7.39
EPS 9.73 9.06 7.39
EBITDA 2058.10 1807.40 13.87
The company net profit jumps to Rs. 1323.00 million against Rs. 1232.00 million in the corresponding quarter
ending of previous year, an increase of 7.39%. Revenue for the quarter rose by 11.51% to Rs. 9272.80 million
from Rs. 8315.30 million, when compared with the prior year period. Reported earnings per share of the
company stood at Rs.9.73 a share during the quarter, registering 7.39% increase over previous year period.
Profit before interest, depreciation and tax is Rs. 2058.10 million as against Rs. 1807.40 million in the
corresponding period of the previous year.
Expenditure :
During the quarter total expenditure cost raised
by 10 per cent an account of increase in material
consumed cost along with consideration of
advertising cost. Total expenditure in Q4 FY14 was
Rs. 7407.10 million as against Rs. 6741.50 million in
Q4 FY13. Other expenses are increased to Rs.
2166.80 million against Rs. 1889.80 million in the
corresponding period of the previous year.
Advertising cost is Rs. 994.60 million, and
Consumption of Raw Materials is Rs. 3512.00
million in Q4 FY14 are primarily attributable to
growth of expenditure.
Latest Updates
• In March, 2014, Colgate Palmolive (India) Ltd has declared a third interim dividend of Rs. 9/- per equity
share of Re. 1/- (face value) for the financial year ending March 31, 2014. The Company has paid first and
second interim dividends of Rs. 9 per share each paid in November, 2013 and December, 2013 respectively,
The Company has paid a total interim dividend Rs. 27 per share for the financial year ending March 31, 2014.
• The Company posted a robust volume growth of 7% for the quarter and 9% for the full year in Toothpaste
and continued to enhance its leadership position in Toothpaste category by registering a volume market
share of 57.1% for the period Jan’14-Apr’14, an increase of 170 basis points over the same period of the
previous year
• The Company further strengthened its leadership position in the Toothbrush category by registering a
volume market share of 42.3% for Jan’14-Apr’14, an increase of 100 basis points over the same period of the
previous year.
• Commercial production of toothpaste has commenced on May 21, 2014 at Company's new manufacturing
facility set up at Sanand, Gujarat. Further, the Company has announced that in the month of March 2014 the
new manufacturing facility was commissioned and fully tested. In the initial phase, the Company intend to
manufacture 15,000 MTs toothpaste from this manufacturing facility.
Company Profile
Colgate-Palmolive (India) Limited is India’s leading provider of scientifically proven oral care products with
multiple benefits at various price points. The range includes toothpastes, toothpowder, toothbrushes and
mouthwashes under the “Colgate” brand, as well as a specialized range of dental therapies under the banner of
Colgate Oral Pharmaceuticals. These have become an essential part of daily oral hygiene and therapeutic oral
care in India. The Company also provides a range of personal care products under the ‘Palmolive’ brand name.
Colgate has been ranked as India’s #1 Most Trusted Brand across all categories for four consecutive years from
2003 to 2007 and in 2011 and 2012 by Brand Equity’s Most Trusted Brand Survey. It is the only brand to be in
the top three from 2001-2012.
In November 2007, it acquired a 75% equity interest in Advanced Oral Care Products, Professional Oral Care
Products and SS Oral Hygiene Products, the company is the fastest growing and one of the oldest companies
catering to the personal care products. The company is regularly coming up with new products and has been a
consistent financial performer.
Products
• Oral care- Under this segment the company offers product like toothpastes, toothbrush, tooth powder &
tooth whitening products.
• Personal care -In this segment it offer products skin care, hair care, body wash, & shaving creams
• Household care- Under this segment it has launched brand AXIOM-a dish washing paste.
Financial Highlight (PARENT BASIS) (A*- Actual, E* -Estimations & Rs. In Millions)
Balance sheet as at March31st, 2013-2016E
FY13A FY14A FY15E FY16E
SOURCES OF FUNDS
Shareholder's Funds
Share Capital 136.00 136.00 136.00 136.00
Reserves and Surplus 4759.92 5862.80 7211.24 8509.27
1. Sub Total - Net worth 4895.92 5998.80 7347.24 8645.27
Non Current Liabilities
Other Long term Liabilities 8.44 7.40 7.77 8.16
Long Term Provisions 349.00 248.60 218.77 236.27
2. Sub Total - Non Current Liabilities 357.44 256.00 226.54 244.43
Current Liabilities
Trade Payables 4666.20 5099.70 5405.68 5675.97
Other Current Liabilities 2501.80 2829.40 3084.05 3299.93
Short Term Provisions 646.41 703.60 745.82 783.11
3. Sub Total - Current Liabilities 7814.41 8632.70 9235.54 9759.00
Total Liabilities (1+2+3) 13067.77 14887.50 16809.33 18648.70
APPLICATION OF FUNDS
Non-Current Assets
a) Fixed Assets 3826.19 6974.20 8292.04 9535.85
b) Non-current investments 371.35 371.30 389.87 401.56
c) Deferred Tax Asset 224.45 177.80 154.69 139.22
d) Long Term loans and advances 702.95 625.60 656.88 683.16
e) Other non-current assets 12.46 20.60 23.69 26.53
1. Sub Total - Non Current Assets 5137.40 8169.50 9517.16 10786.31
Current Assets
Current Investments 99.82 0.00 0.00 0.00
Inventories 1852.98 2257.40 2573.44 2848.08
Trade receivables 812.11 547.40 470.76 499.01
Cash and Bank Balances 4287.96 2869.50 3099.06 3285.00
Short-terms loans & advances 844.71 1027.00 1129.70 1208.78
Other current assets 32.79 16.70 19.21 21.51
2. Sub Total - Current Assets 7930.37 6718.00 7292.17 7862.39
Total Assets (1+2) 13067.77 14887.50 16809.33 18648.70
Annual Profit & Loss Statement for the period of 2013 to 2016E
Value(Rs.in.mn) FY13A FY14A FY15E FY16E
Description 12m 12m 12m 12m
Net Sales 31638.10 35788.10 40082.67 44090.94
Other Income 499.20 503.20 478.04 497.16
Total Income 32137.30 36291.30 40560.71 44588.10
Expenditure -25070.00 -29148.00 -32507.05 -35845.93
Operating Profit 7067.30 7143.30 8053.67 8742.17
Interest 0.00 0.00 0.00 0.00
Gross profit 7067.30 7143.30 8053.67 8742.17
Depreciation -437.00 -507.50 -573.48 -630.82
Exceptional Items 0.00 643.80 0.00 0.00
Profit Before Tax 6630.30 7279.60 7480.19 8111.34
Tax -1662.80 -1880.90 -2049.57 -2149.51
Net Profit 4967.50 5398.70 5430.62 5961.84
Equity capital 136.00 136.00 136.00 136.00
Reserves 4759.90 5862.80 7211.24 8509.27
Face value 1.00 1.00 1.00 1.00
EPS 36.53 39.70 39.93 43.84
Quarterly Profit & Loss Statement for the period of 30th Sep, 2013 to 30th June, 2014E
Value(Rs.in.mn) 30-Sep-13 31-Dec-13 31-Mar-14 30-Jun-14E
Description 3m 3m 3m 3m
Net sales 9007.30 8911.10 9272.80 9643.71
Other income 130.20 162.40 39.40 52.80
Total Income 9137.50 9073.50 9312.20 9696.51
Expenditure -7544.00 -7405.80 -7254.10 -7734.26
Operating profit 1593.50 1667.70 2058.10 1962.25
Interest 0.00 0.00 0.00 0.00
Gross profit 1593.50 1667.70 2058.10 1962.25
Depreciation -116.60 -120.50 -153.00 -159.12
Exceptional Items 0.00 -1.10 -61.50 0.00
Profit Before Tax 1476.90 1546.10 1843.60 1803.13
Tax -381.70 -417.80 -520.60 -513.89
Net Profit 1095.20 1128.30 1323.00 1289.24
Equity capital 136.00 136.00 136.00 136.00
Face value 1.00 1.00 1.00 1.00
EPS 8.05 8.30 9.73 9.48
Ratio Analysis
Particulars FY13A FY14A FY15E FY16E
EPS (Rs.) 36.53 39.70 39.93 43.84
EBITDA Margin (%) 22.34% 19.96% 20.09% 19.83%
PBT Margin (%) 20.96% 20.34% 18.66% 18.40%
PAT Margin (%) 15.70% 15.09% 13.55% 13.52%
P/E Ratio (x) 36.91 33.96 33.76 30.75
ROE (%) 101.46% 90.00% 73.91% 68.96%
ROCE (%) 153.28% 127.54% 117.42% 108.42%
EV/EBITDA (x) 25.32 25.26 22.38 20.59
Book Value (Rs.) 36.00 44.11 54.02 63.57
P/BV 37.45 30.56 24.95 21.21
Charts
Outlook and Conclusion
At the current market price of Rs.1348.00, the stock P/E ratio is at 33.76 x FY15E and 30.75 x FY16E
respectively.
Earning per share (EPS) of the company for the earnings for FY15E and FY16E is seen at Rs. 39.93 and Rs.
43.84 respectively.
Net Sales and PAT of the company are expected to grow at a CAGR of 12% and 6% over 2013 to 2016E
respectively.
On the basis of EV/EBITDA, the stock trades at 22.38 x for FY15E and 20.59 x for FY16E.
Price to Book Value of the stock is expected to be at 24.95 x and 21.21 x respectively for FY15E and FY16E.
We recommend ‘BUY’ in this particular scrip with a target price of Rs.1510.00 for Medium to Long term
investment.
Industry Overview
The Indian Fast Moving Consumer Goods (FMCG) sector is the fourth largest in the Indian economy and has a
market size of $13.1 billion. This industry primarily includes the production, distribution and marketing of
consumer packaged goods, that is those categories of products which are consumed at regular intervals.
The FMCG market is set to treble US$ 33.4 billion in 2015. Penetration level as well as per capita consumption in
most product categories like jams, toothpaste, skin care, hair wash etc in India is low indicating the untapped
market potential.
The Indian FMCG industry represents nearly 2.5% of the country’s GDP.
The industry has tripled in size in past 10 years and has grown at ~17%CAGR in the last 5 years driven by
rising income levels, increasing urbanization, strong rural demand and favourable demographic trends.
The sector accounted for 1.9% of the nation’s total FDI inflows in April 2000- September 2012. Cumulative
FDI inflows into India from April 2000 to April 2013 in the food processing sector stood at Rs. 9,000.3 crore,
accounting for 0.96% of overall FDI inflows while the soaps, cosmetics and toiletries, accounting for 0.32% of
overall FDI at Rs. 3,115.5 crore.
Food products and personal care together make up two-third of the sector’s revenues.
Rural India accounts for more than 700 mn consumers or 70% of the Indian population and accounts for
50% of the total FMCG market.
With changing lifestyle and increasing consumer demand, the Indian FMCG market is expected to cross $80
bn by 2026 in towns with population of up to 10 lakh.
India's labor cost is amongst the lowest in the world, after China & Indonesia, giving it a competitive
advantage over other countries.
Household care
The fabric wash market size is estimated to be ~USD 1 billion, household cleaners to be USD 239 million, with
the production of synthetic detergents at 2.6 million tonnes. The demand for detergents has been growing at an
annual growth rate of 10 to 11% during the past five years
Personal Care (HPC)
The personal care products (PCP) market in India is estimated to be worth ~USD 4 bn p.a. Personal hygiene
products (including bath and shower products, deodorants etc.), hair care, skin care, colour cosmetics and
fragrances are the key segments of the personal care market.
Food & Beverages
Food processing industry is one of the largest industries in India, ranking fifth in terms of production, growth,
consumption, and export. The total value of Indian food processing industry is expected to touch USD 194 billion
by 2015 from a value of USD 121 billion in 2012, according to Indian Council of Agricultural Research (ICAR).
Expenditure on advertisements by FMCG Companies in 2013
Fast-moving consumer goods (FMCG) companies, a safe haven through most of the slowdown, have felt
consumption blues of late. While the annual revenues of these companies have increased 15-20 per cent, their
advertisement and sales promotions spends have raised 25-30 a year.
ITC, one of the biggest companies in the Indian FMCG space, spent Rs 806.65 crore on advertising in 2012-13,
against Rs 682.69 crore in 2011-12. At Rs 502.37 crore, Dabur India’s ad spends jumped 27 per cent in 2012-13.
In 2012-13, Hindustan Unilever spent Rs 3,231.88 crore on advertising and promotional activities, compared
with Rs 2,634.79 crore the previous financial year, a rise of 22.66 per cent. During the same period, Emami’s
spends rose 21.18 per cent to Rs 253.11 crore.
Government Policies and Regulatory Framework
Goods and Service Tax (GST): GST, which will replace the multiple indirect taxes levied on FMCG sector with a
uniform, simplified and single-pint taxation system, is likely to be implemented soon (the benefits are likely to
come in by the end of FY’14). The rate of GST on services is likely to be 16% and on goods is proposed to be 20%.
A swift move to the proposed GST may reduce prices, bolstering consumption for FMCG products.
Food Security Bill: The food security Bill has been passed recently by the Union Cabinet. As per the Bill, 5Kg of
food grains per person per month will be provided at subsidized prices from State Governments under the
targeted public distribution system.
FDI in retail: The decision to allow 51% FDI in multi brand retail and 100% FDI in single brand retail augers
well for the outlook for the FMCG sector. FMCG sector accounted for 1.9% of the nation’s total FDI inflows in
April 2000- September 2012. Cumulative FDI inflows into India from April 2000 to April 2013 in the food
processing sector stood at Rs. 9,000.33 crore, accounting for 0.96% of overall FDI inflows while that in the soaps,
cosmetics and toiletries was Rs. 3,115.54 crore in, accounting for 0.32%. The food processing sector attracted
FDI inflows of Rs. 6,198 crore during April 2009 to December 2012.
Relaxation of license rules: Industrial licenses are not required for almost all food and agro-processing
industries, barring certain items such as beer, potable alcohol and wines, cane sugar, and hydrogenated animal
fats and oils as well as items reserved for exclusive manufacturing in the small-scale sector.
Conclusion
While the rural market certainly offers a big attraction to marketers, it would be naïve to think that any company
can enter the market without facing any problems and walk away with a sizable share. Distribution is the most
important variable in the marketing plans of most consumer goods manufacturers, because managing such a
massive sales and distribution network is in itself a huge task.
This sector will continue to see growth as it depends on an ever-increasing internal market for consumption, and
demand for these goods remains more or less constant, irrespective of recession or inflation. Hence this sector
will grow, though it may not be a smooth growth path, due to the present world-wide economic slowdown, rising
inflation and fall of the rupee. This sector will see good growth in the long run and hiring will continue to remain
robust.
Disclaimer:
This document prepared by our research analysts does not constitute an offer or solicitation for the purchase or sale
of any financial instrument or as an official confirmation of any transaction. The information contained herein is
from publicly available data or other sources believed to be reliable but do not represent that it is accurate or
complete and it should not be relied on as such. Firstcall India Equity Advisors Pvt. Ltd. or any of it’s affiliates shall
not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this report. This document is provide for assistance only and is not intended to be and must
not alone be taken as the basis for an investment decision.
Firstcall India Equity Research: Email – info@firstcallindia.com
C.V.S.L.Kameswari Pharma
U. Janaki Rao Capital Goods
B. Anil Kumar Auto, IT & FMCG
Suhani Adilabadkar Pharma & Banking
M. Vinayak Rao Diversified
C. Bhagya Lakshmi Diversified
Firstcall India also provides
Firstcall India Equity Advisors Pvt.Ltd focuses on, IPO’s, QIP’s, F.P.O’s,Takeover
Offers, Offer for Sale and Buy Back Offerings.
Corporate Finance Offerings include Foreign Currency Loan Syndications,
Placement of Equity / Debt with multilateral organizations, Short Term Funds
Management Debt & Equity, Working Capital Limits, Equity & Debt
Syndications and Structured Deals.
Corporate Advisory Offerings include Mergers & Acquisitions(domestic and
cross-border), divestitures, spin-offs, valuation of business, corporate
restructuring-Capital and Debt, Turnkey Corporate Revival – Planning &
Execution, Project Financing, Venture capital, Private Equity and Financial
Joint Ventures
Firstcall India also provides Financial Advisory services with respect to raising
of capital through FCCBs, GDRs, ADRs and listing of the same on International
Stock Exchanges namely AIMs, Luxembourg, Singapore Stock Exchanges and
other international stock exchanges.
For Further Details Contact:
3rd Floor,Sankalp,The Bureau,Dr.R.C.Marg,Chembur,Mumbai 400 071
Tel. : 022-2527 2510/2527 6077/25276089 Telefax : 022-25276089
E-mail: info@firstcallindiaequity.com
www.firstcallindiaequity.com

More Related Content

What's hot

asian paints financial management
asian paints financial managementasian paints financial management
asian paints financial managementharshidoshi
 
Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...
Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...
Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...Katalyst Wealth
 
Engro foods presentation (financial accounting)
Engro foods presentation (financial accounting)Engro foods presentation (financial accounting)
Engro foods presentation (financial accounting)Shahroz Saleem
 
Asian paints finance presentation
Asian paints finance presentationAsian paints finance presentation
Asian paints finance presentationparthproy
 
Engro foods report (fsa)
Engro foods report (fsa)Engro foods report (fsa)
Engro foods report (fsa)Mohammad Waseem
 
Summer training project (PPTs)
Summer training project (PPTs)Summer training project (PPTs)
Summer training project (PPTs)Vishaal
 
Asian paints mar-12
Asian paints   mar-12Asian paints   mar-12
Asian paints mar-12badanihiren
 
Uploaded file 129830910600781250
Uploaded file 129830910600781250Uploaded file 129830910600781250
Uploaded file 129830910600781250ANANT AGARWAL
 
Go long on Page Industries, Q4FY15 net sales up 34.24% y/y
Go long on Page Industries, Q4FY15 net sales up 34.24% y/yGo long on Page Industries, Q4FY15 net sales up 34.24% y/y
Go long on Page Industries, Q4FY15 net sales up 34.24% y/yIndiaNotes.com
 
Pidilite Industry
Pidilite IndustryPidilite Industry
Pidilite IndustryMusaPehlari
 
Mazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha Recommendation
Mazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha RecommendationMazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha Recommendation
Mazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha RecommendationKatalyst Wealth
 
Asian Paints - Resource Based Perspective
Asian Paints - Resource Based PerspectiveAsian Paints - Resource Based Perspective
Asian Paints - Resource Based PerspectiveYashowardhan Chaturvedi
 
Marico presentation final
Marico presentation finalMarico presentation final
Marico presentation finalAmit Trivedi
 
Firstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/y
Firstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/yFirstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/y
Firstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/yIndiaNotes.com
 

What's hot (20)

asian paints financial management
asian paints financial managementasian paints financial management
asian paints financial management
 
Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...
Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...
Control Print Ltd (BSE Code 522295) - May'14 Katalyst Wealth Alpha Recommenda...
 
Engro foods presentation (financial accounting)
Engro foods presentation (financial accounting)Engro foods presentation (financial accounting)
Engro foods presentation (financial accounting)
 
Asian paints finance presentation
Asian paints finance presentationAsian paints finance presentation
Asian paints finance presentation
 
Engro foods report (fsa)
Engro foods report (fsa)Engro foods report (fsa)
Engro foods report (fsa)
 
Accounting report
Accounting reportAccounting report
Accounting report
 
Summer training project (PPTs)
Summer training project (PPTs)Summer training project (PPTs)
Summer training project (PPTs)
 
Asian paints mar-12
Asian paints   mar-12Asian paints   mar-12
Asian paints mar-12
 
Alembic pharma multibagger-jan-2016
Alembic pharma   multibagger-jan-2016Alembic pharma   multibagger-jan-2016
Alembic pharma multibagger-jan-2016
 
Uploaded file 129830910600781250
Uploaded file 129830910600781250Uploaded file 129830910600781250
Uploaded file 129830910600781250
 
Go long on Page Industries, Q4FY15 net sales up 34.24% y/y
Go long on Page Industries, Q4FY15 net sales up 34.24% y/yGo long on Page Industries, Q4FY15 net sales up 34.24% y/y
Go long on Page Industries, Q4FY15 net sales up 34.24% y/y
 
Pidilite Industry
Pidilite IndustryPidilite Industry
Pidilite Industry
 
Mazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha Recommendation
Mazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha RecommendationMazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha Recommendation
Mazda Ltd (BSE Code 523792) - Apr'12 Katalyst Wealth Alpha Recommendation
 
5 stocks based on gst event
5 stocks based on gst event5 stocks based on gst event
5 stocks based on gst event
 
5 growth stocks 24-04-16
5 growth stocks 24-04-165 growth stocks 24-04-16
5 growth stocks 24-04-16
 
U flex ltd multibagger-apr-2016
U flex ltd   multibagger-apr-2016U flex ltd   multibagger-apr-2016
U flex ltd multibagger-apr-2016
 
Nandan denim multibagger
Nandan denim  multibaggerNandan denim  multibagger
Nandan denim multibagger
 
Asian Paints - Resource Based Perspective
Asian Paints - Resource Based PerspectiveAsian Paints - Resource Based Perspective
Asian Paints - Resource Based Perspective
 
Marico presentation final
Marico presentation finalMarico presentation final
Marico presentation final
 
Firstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/y
Firstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/yFirstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/y
Firstcall recommend TCPL Packaging, Q4FY15 net profits up 104.53% y/y
 

Similar to Colgate Palmolive: Revenue grows 11.51% to Rs9272.80 mn in Q4FY14, buy - Firstcall India Equity

Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...
Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...
Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalIndiaNotes.com
 
Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]IndiaNotes.com
 
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'IndiaNotes.com
 
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/yFirstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/yIndiaNotes.com
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyIndiaNotes.com
 
Cadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buy
Cadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buyCadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buy
Cadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buyIndiaNotes.com
 
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docxRunning head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docxcharisellington63520
 
Business Analysis Assignment - Zydus Wellness
Business Analysis Assignment - Zydus WellnessBusiness Analysis Assignment - Zydus Wellness
Business Analysis Assignment - Zydus WellnessNirin Parikh
 
Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Alkesh Parihar
 
Assignment final (1)
Assignment final (1)Assignment final (1)
Assignment final (1)wyinsam
 
Firstcall claris lifesciences_ltd_30 june15
Firstcall claris lifesciences_ltd_30 june15Firstcall claris lifesciences_ltd_30 june15
Firstcall claris lifesciences_ltd_30 june15IndiaNotes.com
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buyIndiaNotes.com
 
Account Assignment final
Account Assignment finalAccount Assignment final
Account Assignment finalYcnigel
 
PFC Q4FY15: Surplus scenario likely to continue for next three years
PFC Q4FY15: Surplus scenario likely to continue for next three yearsPFC Q4FY15: Surplus scenario likely to continue for next three years
PFC Q4FY15: Surplus scenario likely to continue for next three yearsIndiaNotes.com
 
Corporate story on dabur
Corporate story on daburCorporate story on dabur
Corporate story on daburAnkur Tyagi
 
Corporate story on dabur
Corporate story on daburCorporate story on dabur
Corporate story on daburAnkur Tyagi
 

Similar to Colgate Palmolive: Revenue grows 11.51% to Rs9272.80 mn in Q4FY14, buy - Firstcall India Equity (20)

Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...
Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...
Nestle: Net profit ramps up by 6.07% to Rs2878.60 mn, buy - Firstcall India E...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Dabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal OswalDabur Q4FY14 results in line with expectations by Motilal Oswal
Dabur Q4FY14 results in line with expectations by Motilal Oswal
 
Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]
 
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
Multibase India's FY15 net profit up 42% y/y, Firstcall recommend 'Buy'
 
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/yFirstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
Firstcall recommend this pharma scrip after Q4FY15 revenue rise 18.10% y/y
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
 
Cadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buy
Cadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buyCadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buy
Cadila Healthcare: Recommends dividend @ 240% for FY15; Maintain buy
 
Relaxo footwear
Relaxo footwearRelaxo footwear
Relaxo footwear
 
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docxRunning head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
Running head MARKET POSITION ANALYSIS 1MARKET POSITION ANALYSI.docx
 
Business Analysis Assignment - Zydus Wellness
Business Analysis Assignment - Zydus WellnessBusiness Analysis Assignment - Zydus Wellness
Business Analysis Assignment - Zydus Wellness
 
Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)Project on lupin pharmaceutical(3) (1)
Project on lupin pharmaceutical(3) (1)
 
Assignment final (1)
Assignment final (1)Assignment final (1)
Assignment final (1)
 
Firstcall claris lifesciences_ltd_30 june15
Firstcall claris lifesciences_ltd_30 june15Firstcall claris lifesciences_ltd_30 june15
Firstcall claris lifesciences_ltd_30 june15
 
Guidance presentation jan 2014 final
Guidance presentation jan 2014 finalGuidance presentation jan 2014 final
Guidance presentation jan 2014 final
 
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 Sanofi India: Q2CY14 net rises 12.30%, maintain buy Sanofi India: Q2CY14 net rises 12.30%, maintain buy
Sanofi India: Q2CY14 net rises 12.30%, maintain buy
 
Account Assignment final
Account Assignment finalAccount Assignment final
Account Assignment final
 
PFC Q4FY15: Surplus scenario likely to continue for next three years
PFC Q4FY15: Surplus scenario likely to continue for next three yearsPFC Q4FY15: Surplus scenario likely to continue for next three years
PFC Q4FY15: Surplus scenario likely to continue for next three years
 
Corporate story on dabur
Corporate story on daburCorporate story on dabur
Corporate story on dabur
 
Corporate story on dabur
Corporate story on daburCorporate story on dabur
Corporate story on dabur
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Colgate Palmolive: Revenue grows 11.51% to Rs9272.80 mn in Q4FY14, buy - Firstcall India Equity

  • 1. Recommendation BUY CMP 1348.00 Target Price 1510.00 ISIN: INE259A01022 MAY 28th , 2014 COLGATE-PALMOLIVE (INDIA) LTD Result Update (PARENT BASIS): Q4 FY14 STOCK DETAILS Sector FMCG BSE Code 500830 Face Value 1.00 52wk. High / Low (Rs.) 1522.95/1190.05 Volume (2wk. Avg ) 20000 Market Cap ( Rs in mn ) 183328.00 Annual Estimated Results (A*: Actual / E*: Estimated) Years FY14A FY15E FY16E Net Sales 35788.10 40082.67 44090.94 EBITDA 7143.30 8053.67 8742.17 Net Profit 5398.70 5430.62 5961.84 EPS 39.70 39.93 43.84 P/E 33.96 33.76 30.75 Shareholding Pattern (%) 1 Year Comparative Graph COLGATE-PALMOLIVE (INDIA) LTD S&P BSE SENSEX SYNOPSIS Colgate Palmolive (India) Limited is India’s leading provider of scientifically proven oral care products with multiple benefits at various price points. During the quarter, net profit jumps to Rs. 1323.00 mn against Rs. 1232.00 mn in the corresponding quarter ending of previous year, an increase of 7.39%. Revenue for the quarter rose by 11.51% to Rs. 9272.80 mn from Rs. 8315.30 mn, when compared with the prior year period. The Company posted a robust volume growth of 7% for the quarter and 9% for the full year in Toothpaste category. Toothpaste category registered a volume market share of 57.1% for the period Jan’14-Apr’14, an increase of 170 basis points over the same period of the previous year. The Company’s Toothbrush category registered a volume market share of 42.3% for Jan’14-Apr’14, an increase of 100 basis points over the same period of the previous year. For the year ended March 31, 2014, net sales increased by 13% to Rs. 35788.1 mn as against Rs. 31638.1 mn in the previous year. In March, 2014, the Company has declared a third interim dividend of Rs. 9/- per equity share of Re. 1/- each for the financial year ending March 31, 2014. Commercial production of toothpaste has commenced on May 21, 2014 at Company's new manufacturing facility set up at Sanand, Gujarat. Net Sales and PAT of the company are expected to grow at a CAGR of 12% and 6% over 2013 to 2016E respectively. PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND COMPANY NAME (Rs.) Rs. in Mn. (Rs.) Ratio Ratio (%) Colgate-Palmolive (India) Ltd 1348.00 183328.00 39.70 33.96 30.56 2700.00 P&G Hygiene and Health Care Ltd 3850.00 124973.80 81.33 47.34 15.52 250.00 Dabur India Ltd 180.25 313101.60 3.85 46.64 19.62 175.00 HUL Ltd 561.00 1207108.90 17.88 31.22 45.16 1300.00
  • 2. Recommendation & Analysis - ‘BUY’ Net sales for the fourth quarter of current financial year 2013-14, was Rs. 9272.80 mn, an 11.51% increase over the same quarter of the previous year and Net profit after Tax of Rs. 1323.0 mn with Earnings per share of Rs. 9.73. For the year ended March 31st, 2014, net sales increased by 13% to Rs. 35788.1 mn as against Rs. 31638.1 mn in the previous year and Net profit after Tax (including exceptional item) of Rs. 5398.7 mn with Earnings per share of Rs. 39.70, an increase of 9% over the previous year. The Company posted a robust volume growth of 7% for the quarter and 9% for the full year in Toothpaste and continued to enhance its leadership position in Toothpaste category by registering a volume market share of 57.1% for the period Jan’14-Apr’14, an increase of 170 basis points over the same period of the previous year. The flagship brands “Colgate Dental Cream”, “Active Salt”, “Max Fresh” and “Colgate Total” along with the recently launched “Visible White” have contributed to this growth. The Company further strengthened its leadership position in the Toothbrush category by registering a volume market share of 42.3% for Jan’14-Apr’14, an increase of 100 basis points over the same period of the previous year. Colgate has, for the third consecutive year from 2011 to 2013, been ranked as India’s #1 Most Trusted Brand across all categories by Brand Equity’s Most Trusted Brand Survey and is the only brand to feature in the top three since the inception of the survey twelve years ago. Over FY2013-16E, we expect the company to post a CAGR of 12% and 6% in its top-line and bottom-line respectively. Hence, we recommend ‘BUY’ for ‘COLGATE- PALMOLIVE (INDIA) LTD’ with a target price of Rs. 1510.00 for medium to long term investment.
  • 3. FINANCIAL HIGHLIGHTS (PARENT BASIS) Results updates- Q4 FY14, Colgate-Palmolive (India) Limited engages in the manufacture and marketing of fast moving consumer goods in India and internationally, reported its financial results for the quarter ended 31st March, 2014. Months Mar-14 Mar-13 % Change Net Sales 9272.80 8315.30 11.51 PAT 1323.00 1232.00 7.39 EPS 9.73 9.06 7.39 EBITDA 2058.10 1807.40 13.87 The company net profit jumps to Rs. 1323.00 million against Rs. 1232.00 million in the corresponding quarter ending of previous year, an increase of 7.39%. Revenue for the quarter rose by 11.51% to Rs. 9272.80 million from Rs. 8315.30 million, when compared with the prior year period. Reported earnings per share of the company stood at Rs.9.73 a share during the quarter, registering 7.39% increase over previous year period. Profit before interest, depreciation and tax is Rs. 2058.10 million as against Rs. 1807.40 million in the corresponding period of the previous year. Expenditure : During the quarter total expenditure cost raised by 10 per cent an account of increase in material consumed cost along with consideration of advertising cost. Total expenditure in Q4 FY14 was Rs. 7407.10 million as against Rs. 6741.50 million in Q4 FY13. Other expenses are increased to Rs. 2166.80 million against Rs. 1889.80 million in the corresponding period of the previous year. Advertising cost is Rs. 994.60 million, and Consumption of Raw Materials is Rs. 3512.00 million in Q4 FY14 are primarily attributable to growth of expenditure.
  • 4. Latest Updates • In March, 2014, Colgate Palmolive (India) Ltd has declared a third interim dividend of Rs. 9/- per equity share of Re. 1/- (face value) for the financial year ending March 31, 2014. The Company has paid first and second interim dividends of Rs. 9 per share each paid in November, 2013 and December, 2013 respectively, The Company has paid a total interim dividend Rs. 27 per share for the financial year ending March 31, 2014. • The Company posted a robust volume growth of 7% for the quarter and 9% for the full year in Toothpaste and continued to enhance its leadership position in Toothpaste category by registering a volume market share of 57.1% for the period Jan’14-Apr’14, an increase of 170 basis points over the same period of the previous year • The Company further strengthened its leadership position in the Toothbrush category by registering a volume market share of 42.3% for Jan’14-Apr’14, an increase of 100 basis points over the same period of the previous year. • Commercial production of toothpaste has commenced on May 21, 2014 at Company's new manufacturing facility set up at Sanand, Gujarat. Further, the Company has announced that in the month of March 2014 the new manufacturing facility was commissioned and fully tested. In the initial phase, the Company intend to manufacture 15,000 MTs toothpaste from this manufacturing facility. Company Profile Colgate-Palmolive (India) Limited is India’s leading provider of scientifically proven oral care products with multiple benefits at various price points. The range includes toothpastes, toothpowder, toothbrushes and mouthwashes under the “Colgate” brand, as well as a specialized range of dental therapies under the banner of Colgate Oral Pharmaceuticals. These have become an essential part of daily oral hygiene and therapeutic oral care in India. The Company also provides a range of personal care products under the ‘Palmolive’ brand name. Colgate has been ranked as India’s #1 Most Trusted Brand across all categories for four consecutive years from 2003 to 2007 and in 2011 and 2012 by Brand Equity’s Most Trusted Brand Survey. It is the only brand to be in the top three from 2001-2012. In November 2007, it acquired a 75% equity interest in Advanced Oral Care Products, Professional Oral Care Products and SS Oral Hygiene Products, the company is the fastest growing and one of the oldest companies catering to the personal care products. The company is regularly coming up with new products and has been a consistent financial performer.
  • 5. Products • Oral care- Under this segment the company offers product like toothpastes, toothbrush, tooth powder & tooth whitening products. • Personal care -In this segment it offer products skin care, hair care, body wash, & shaving creams • Household care- Under this segment it has launched brand AXIOM-a dish washing paste.
  • 6. Financial Highlight (PARENT BASIS) (A*- Actual, E* -Estimations & Rs. In Millions) Balance sheet as at March31st, 2013-2016E FY13A FY14A FY15E FY16E SOURCES OF FUNDS Shareholder's Funds Share Capital 136.00 136.00 136.00 136.00 Reserves and Surplus 4759.92 5862.80 7211.24 8509.27 1. Sub Total - Net worth 4895.92 5998.80 7347.24 8645.27 Non Current Liabilities Other Long term Liabilities 8.44 7.40 7.77 8.16 Long Term Provisions 349.00 248.60 218.77 236.27 2. Sub Total - Non Current Liabilities 357.44 256.00 226.54 244.43 Current Liabilities Trade Payables 4666.20 5099.70 5405.68 5675.97 Other Current Liabilities 2501.80 2829.40 3084.05 3299.93 Short Term Provisions 646.41 703.60 745.82 783.11 3. Sub Total - Current Liabilities 7814.41 8632.70 9235.54 9759.00 Total Liabilities (1+2+3) 13067.77 14887.50 16809.33 18648.70 APPLICATION OF FUNDS Non-Current Assets a) Fixed Assets 3826.19 6974.20 8292.04 9535.85 b) Non-current investments 371.35 371.30 389.87 401.56 c) Deferred Tax Asset 224.45 177.80 154.69 139.22 d) Long Term loans and advances 702.95 625.60 656.88 683.16 e) Other non-current assets 12.46 20.60 23.69 26.53 1. Sub Total - Non Current Assets 5137.40 8169.50 9517.16 10786.31 Current Assets Current Investments 99.82 0.00 0.00 0.00 Inventories 1852.98 2257.40 2573.44 2848.08 Trade receivables 812.11 547.40 470.76 499.01 Cash and Bank Balances 4287.96 2869.50 3099.06 3285.00 Short-terms loans & advances 844.71 1027.00 1129.70 1208.78 Other current assets 32.79 16.70 19.21 21.51 2. Sub Total - Current Assets 7930.37 6718.00 7292.17 7862.39 Total Assets (1+2) 13067.77 14887.50 16809.33 18648.70
  • 7. Annual Profit & Loss Statement for the period of 2013 to 2016E Value(Rs.in.mn) FY13A FY14A FY15E FY16E Description 12m 12m 12m 12m Net Sales 31638.10 35788.10 40082.67 44090.94 Other Income 499.20 503.20 478.04 497.16 Total Income 32137.30 36291.30 40560.71 44588.10 Expenditure -25070.00 -29148.00 -32507.05 -35845.93 Operating Profit 7067.30 7143.30 8053.67 8742.17 Interest 0.00 0.00 0.00 0.00 Gross profit 7067.30 7143.30 8053.67 8742.17 Depreciation -437.00 -507.50 -573.48 -630.82 Exceptional Items 0.00 643.80 0.00 0.00 Profit Before Tax 6630.30 7279.60 7480.19 8111.34 Tax -1662.80 -1880.90 -2049.57 -2149.51 Net Profit 4967.50 5398.70 5430.62 5961.84 Equity capital 136.00 136.00 136.00 136.00 Reserves 4759.90 5862.80 7211.24 8509.27 Face value 1.00 1.00 1.00 1.00 EPS 36.53 39.70 39.93 43.84 Quarterly Profit & Loss Statement for the period of 30th Sep, 2013 to 30th June, 2014E Value(Rs.in.mn) 30-Sep-13 31-Dec-13 31-Mar-14 30-Jun-14E Description 3m 3m 3m 3m Net sales 9007.30 8911.10 9272.80 9643.71 Other income 130.20 162.40 39.40 52.80 Total Income 9137.50 9073.50 9312.20 9696.51 Expenditure -7544.00 -7405.80 -7254.10 -7734.26 Operating profit 1593.50 1667.70 2058.10 1962.25 Interest 0.00 0.00 0.00 0.00 Gross profit 1593.50 1667.70 2058.10 1962.25 Depreciation -116.60 -120.50 -153.00 -159.12 Exceptional Items 0.00 -1.10 -61.50 0.00 Profit Before Tax 1476.90 1546.10 1843.60 1803.13 Tax -381.70 -417.80 -520.60 -513.89 Net Profit 1095.20 1128.30 1323.00 1289.24 Equity capital 136.00 136.00 136.00 136.00 Face value 1.00 1.00 1.00 1.00 EPS 8.05 8.30 9.73 9.48
  • 8. Ratio Analysis Particulars FY13A FY14A FY15E FY16E EPS (Rs.) 36.53 39.70 39.93 43.84 EBITDA Margin (%) 22.34% 19.96% 20.09% 19.83% PBT Margin (%) 20.96% 20.34% 18.66% 18.40% PAT Margin (%) 15.70% 15.09% 13.55% 13.52% P/E Ratio (x) 36.91 33.96 33.76 30.75 ROE (%) 101.46% 90.00% 73.91% 68.96% ROCE (%) 153.28% 127.54% 117.42% 108.42% EV/EBITDA (x) 25.32 25.26 22.38 20.59 Book Value (Rs.) 36.00 44.11 54.02 63.57 P/BV 37.45 30.56 24.95 21.21 Charts
  • 9. Outlook and Conclusion At the current market price of Rs.1348.00, the stock P/E ratio is at 33.76 x FY15E and 30.75 x FY16E respectively. Earning per share (EPS) of the company for the earnings for FY15E and FY16E is seen at Rs. 39.93 and Rs. 43.84 respectively. Net Sales and PAT of the company are expected to grow at a CAGR of 12% and 6% over 2013 to 2016E respectively. On the basis of EV/EBITDA, the stock trades at 22.38 x for FY15E and 20.59 x for FY16E. Price to Book Value of the stock is expected to be at 24.95 x and 21.21 x respectively for FY15E and FY16E. We recommend ‘BUY’ in this particular scrip with a target price of Rs.1510.00 for Medium to Long term investment. Industry Overview The Indian Fast Moving Consumer Goods (FMCG) sector is the fourth largest in the Indian economy and has a market size of $13.1 billion. This industry primarily includes the production, distribution and marketing of consumer packaged goods, that is those categories of products which are consumed at regular intervals. The FMCG market is set to treble US$ 33.4 billion in 2015. Penetration level as well as per capita consumption in most product categories like jams, toothpaste, skin care, hair wash etc in India is low indicating the untapped market potential. The Indian FMCG industry represents nearly 2.5% of the country’s GDP. The industry has tripled in size in past 10 years and has grown at ~17%CAGR in the last 5 years driven by rising income levels, increasing urbanization, strong rural demand and favourable demographic trends. The sector accounted for 1.9% of the nation’s total FDI inflows in April 2000- September 2012. Cumulative FDI inflows into India from April 2000 to April 2013 in the food processing sector stood at Rs. 9,000.3 crore, accounting for 0.96% of overall FDI inflows while the soaps, cosmetics and toiletries, accounting for 0.32% of overall FDI at Rs. 3,115.5 crore. Food products and personal care together make up two-third of the sector’s revenues.
  • 10. Rural India accounts for more than 700 mn consumers or 70% of the Indian population and accounts for 50% of the total FMCG market. With changing lifestyle and increasing consumer demand, the Indian FMCG market is expected to cross $80 bn by 2026 in towns with population of up to 10 lakh. India's labor cost is amongst the lowest in the world, after China & Indonesia, giving it a competitive advantage over other countries. Household care The fabric wash market size is estimated to be ~USD 1 billion, household cleaners to be USD 239 million, with the production of synthetic detergents at 2.6 million tonnes. The demand for detergents has been growing at an annual growth rate of 10 to 11% during the past five years Personal Care (HPC) The personal care products (PCP) market in India is estimated to be worth ~USD 4 bn p.a. Personal hygiene products (including bath and shower products, deodorants etc.), hair care, skin care, colour cosmetics and fragrances are the key segments of the personal care market. Food & Beverages Food processing industry is one of the largest industries in India, ranking fifth in terms of production, growth, consumption, and export. The total value of Indian food processing industry is expected to touch USD 194 billion by 2015 from a value of USD 121 billion in 2012, according to Indian Council of Agricultural Research (ICAR). Expenditure on advertisements by FMCG Companies in 2013 Fast-moving consumer goods (FMCG) companies, a safe haven through most of the slowdown, have felt consumption blues of late. While the annual revenues of these companies have increased 15-20 per cent, their advertisement and sales promotions spends have raised 25-30 a year. ITC, one of the biggest companies in the Indian FMCG space, spent Rs 806.65 crore on advertising in 2012-13, against Rs 682.69 crore in 2011-12. At Rs 502.37 crore, Dabur India’s ad spends jumped 27 per cent in 2012-13. In 2012-13, Hindustan Unilever spent Rs 3,231.88 crore on advertising and promotional activities, compared with Rs 2,634.79 crore the previous financial year, a rise of 22.66 per cent. During the same period, Emami’s spends rose 21.18 per cent to Rs 253.11 crore.
  • 11. Government Policies and Regulatory Framework Goods and Service Tax (GST): GST, which will replace the multiple indirect taxes levied on FMCG sector with a uniform, simplified and single-pint taxation system, is likely to be implemented soon (the benefits are likely to come in by the end of FY’14). The rate of GST on services is likely to be 16% and on goods is proposed to be 20%. A swift move to the proposed GST may reduce prices, bolstering consumption for FMCG products. Food Security Bill: The food security Bill has been passed recently by the Union Cabinet. As per the Bill, 5Kg of food grains per person per month will be provided at subsidized prices from State Governments under the targeted public distribution system. FDI in retail: The decision to allow 51% FDI in multi brand retail and 100% FDI in single brand retail augers well for the outlook for the FMCG sector. FMCG sector accounted for 1.9% of the nation’s total FDI inflows in April 2000- September 2012. Cumulative FDI inflows into India from April 2000 to April 2013 in the food processing sector stood at Rs. 9,000.33 crore, accounting for 0.96% of overall FDI inflows while that in the soaps, cosmetics and toiletries was Rs. 3,115.54 crore in, accounting for 0.32%. The food processing sector attracted FDI inflows of Rs. 6,198 crore during April 2009 to December 2012. Relaxation of license rules: Industrial licenses are not required for almost all food and agro-processing industries, barring certain items such as beer, potable alcohol and wines, cane sugar, and hydrogenated animal fats and oils as well as items reserved for exclusive manufacturing in the small-scale sector. Conclusion While the rural market certainly offers a big attraction to marketers, it would be naïve to think that any company can enter the market without facing any problems and walk away with a sizable share. Distribution is the most important variable in the marketing plans of most consumer goods manufacturers, because managing such a massive sales and distribution network is in itself a huge task. This sector will continue to see growth as it depends on an ever-increasing internal market for consumption, and demand for these goods remains more or less constant, irrespective of recession or inflation. Hence this sector will grow, though it may not be a smooth growth path, due to the present world-wide economic slowdown, rising inflation and fall of the rupee. This sector will see good growth in the long run and hiring will continue to remain robust.
  • 12. Disclaimer: This document prepared by our research analysts does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable but do not represent that it is accurate or complete and it should not be relied on as such. Firstcall India Equity Advisors Pvt. Ltd. or any of it’s affiliates shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This document is provide for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision.
  • 13. Firstcall India Equity Research: Email – info@firstcallindia.com C.V.S.L.Kameswari Pharma U. Janaki Rao Capital Goods B. Anil Kumar Auto, IT & FMCG Suhani Adilabadkar Pharma & Banking M. Vinayak Rao Diversified C. Bhagya Lakshmi Diversified Firstcall India also provides Firstcall India Equity Advisors Pvt.Ltd focuses on, IPO’s, QIP’s, F.P.O’s,Takeover Offers, Offer for Sale and Buy Back Offerings. Corporate Finance Offerings include Foreign Currency Loan Syndications, Placement of Equity / Debt with multilateral organizations, Short Term Funds Management Debt & Equity, Working Capital Limits, Equity & Debt Syndications and Structured Deals. Corporate Advisory Offerings include Mergers & Acquisitions(domestic and cross-border), divestitures, spin-offs, valuation of business, corporate restructuring-Capital and Debt, Turnkey Corporate Revival – Planning & Execution, Project Financing, Venture capital, Private Equity and Financial Joint Ventures Firstcall India also provides Financial Advisory services with respect to raising of capital through FCCBs, GDRs, ADRs and listing of the same on International Stock Exchanges namely AIMs, Luxembourg, Singapore Stock Exchanges and other international stock exchanges. For Further Details Contact: 3rd Floor,Sankalp,The Bureau,Dr.R.C.Marg,Chembur,Mumbai 400 071 Tel. : 022-2527 2510/2527 6077/25276089 Telefax : 022-25276089 E-mail: info@firstcallindiaequity.com www.firstcallindiaequity.com